COX-2 |
Increase in synovial fluid |
|
RA |
[38] |
mPGES-1 |
Increase in synovial fluid |
|
RA |
[38] |
Mice deficient in COX2 |
Null-COX |
CIA reduction |
|
[215] |
Mice deficient in mPGES-1 |
Null-PGES-1 |
CIA reduction |
|
[217] |
PGE2
|
High level in synovial fluid |
|
RA |
[239,240] |
Prostaglandin |
|
Stimulate bone formation |
|
[233] |
Prostaglandin |
|
|
Activate bone resorption in osteoporosis, RA, OA or in periodontis |
[238] |
PGD2
|
|
Stimulate osteoblast calcification |
|
[249] |
PGF2α |
|
Promote osteogenic differentiation |
|
[251] |
15-Deoxy-Δ12,14- prostaglandin J2 |
Prostaglandin D2 metabolite |
Activates PPARγ and TNAP expression |
|
[249] |
n-3 PUFA or conjugated linoleic acid |
Exogenous addition |
Beneficial effects due to modulation of COX-2 |
|
[59] |